Biocon - Mylan’s biosimilar cancer drug `Fulphilia’ gets US FDA approval

06 Jun 2018

Biocon, Sandoz ink global pact for immunology, oncology biosimilar

19 Jan 2018

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally

USFDA seeks details of Biocon’s biosimilar cancer drug pegfilgrastim

10 Oct 2017

Biocon Q1 net profit drops 51.2% to Rs81.3 crore

28 Jul 2017

FDA panel approves Mylan-Biocon’s biosimilar cancer drug

14 Jul 2017

Delhi HC allows Biocon, Mylan to sell generic drug for three types of cancers

04 Mar 2017

Biocon Q1 net up 17% at Rs147 cr, revenues climb 11% to Rs952 cr

23 Jul 2016

Biocon launches insulin for diabetes patients in Japan

15 Jul 2016

Mylan, Biocon report success with Phase 3 Trastuzumab biosimilar cancer drug trials

07 Jun 2016

Biocon inks co-development and marketing pact with Mexican co for rh-insulin

17 Mar 2016

Biocon gets EU nod for generic cholesterol drug

16 Feb 2016

India poor in science, technology investment: Biocon chief

10 Feb 2016

Biocon Q4 net profit surges 78% to Rs202 cr

30 Apr 2015

Biocon plans to set up manufacturing unit in Visakapatanam

15 Dec 2014

Biocon to buy back GE Capital stake in Syngene for Rs215 crore

09 Sep 2014

Biotech firm Biocon ties up with Baxter for new research centre

06 Feb 2014

Biocon to launch breast cancer drug 'CANMAb' next month

18 Jan 2014

Mylan ropes in Biocon’s marketing head Rakesh Bamzai

03 Jan 2014

Mylan Inc today announced that Rakesh Bamzai has joined the company as its president, India commercial and emerging markets

Biocon, Mylan get approval for biosimilar cancer drug Trastuzumab

28 Nov 2013

Biocon reports 13% rise in quarterly net profit at Rs102 crore

26 Oct 2013

Biocon shows 18.65% growth in first-quarter net profit

27 Jul 2013

Kiran Mazumdar-Shaw joins US Pharmacopeial Convention's board of trustees

25 Jan 2013

Biocon receives marketing authorisation for psoriasis drug

08 Jan 2013

Biocon in pact with Bristol-Myers Squibb for oral insulin

16 Nov 2012

Biocon announces positive results from its global phase 3 study with recombinant human insulin

31 Oct 2012